OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Modulating expression of inhibitory and stimulatory immune ‘checkpoints’ using nanoparticulate-assisted nucleic acid delivery
Adam A. Walters, Baljevan Dhadwar, Khuloud T. Al‐Jamal
EBioMedicine (2021) Vol. 73, pp. 103624-103624
Open Access | Times Cited: 8
Adam A. Walters, Baljevan Dhadwar, Khuloud T. Al‐Jamal
EBioMedicine (2021) Vol. 73, pp. 103624-103624
Open Access | Times Cited: 8
Showing 8 citing articles:
Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade
Young‐Jin Choi, Su Hyun Seok, Hong Yeol Yoon, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115306-115306
Open Access | Times Cited: 18
Young‐Jin Choi, Su Hyun Seok, Hong Yeol Yoon, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115306-115306
Open Access | Times Cited: 18
Natural products and their derivatives as immune check point inhibitors: Targeting cytokine/chemokine signalling in cancer
Meenakshi Gupta, Kumari Chandan, Maryam Sarwat
Seminars in Cancer Biology (2022) Vol. 86, pp. 214-232
Closed Access | Times Cited: 32
Meenakshi Gupta, Kumari Chandan, Maryam Sarwat
Seminars in Cancer Biology (2022) Vol. 86, pp. 214-232
Closed Access | Times Cited: 32
The application of nanoparticles in immunotherapy for hepatocellular carcinoma
Xinyao Hu, Hua Zhu, Xiaoqin He, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 85-108
Closed Access | Times Cited: 19
Xinyao Hu, Hua Zhu, Xiaoqin He, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 85-108
Closed Access | Times Cited: 19
Increased co-expression of ICOS and PD-1 predicts poor overall survival in patients with acute myeloid leukemia
Shiyi Pan, Qinghua Cai, Yiqiong Wei, et al.
Immunobiology (2024) Vol. 229, Iss. 3, pp. 152804-152804
Open Access | Times Cited: 3
Shiyi Pan, Qinghua Cai, Yiqiong Wei, et al.
Immunobiology (2024) Vol. 229, Iss. 3, pp. 152804-152804
Open Access | Times Cited: 3
Development of Polymer–Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection
Masatoshi Maeki, Shuya Uno, Kaisei Sugiura, et al.
ACS Applied Materials & Interfaces (2023) Vol. 16, Iss. 2, pp. 2110-2119
Open Access | Times Cited: 9
Masatoshi Maeki, Shuya Uno, Kaisei Sugiura, et al.
ACS Applied Materials & Interfaces (2023) Vol. 16, Iss. 2, pp. 2110-2119
Open Access | Times Cited: 9
The kinetics of inhibitory immune checkpoints during and post-COVID-19: the knowns and unknowns
Ensiye Torki, Arezou Gharezade, Mehrnoosh Doroudchi, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3299-3319
Closed Access | Times Cited: 2
Ensiye Torki, Arezou Gharezade, Mehrnoosh Doroudchi, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3299-3319
Closed Access | Times Cited: 2
Cytokine Response to Nanoparticles Bearing Nucleic Acid Cargo
Daniel Nisakar Meenakshi Sundaram, Mohammad Nasrullah, Hasan Uludağ
Studies in mechanobiology, tissue engineering and biomaterials (2023), pp. 229-266
Closed Access | Times Cited: 1
Daniel Nisakar Meenakshi Sundaram, Mohammad Nasrullah, Hasan Uludağ
Studies in mechanobiology, tissue engineering and biomaterials (2023), pp. 229-266
Closed Access | Times Cited: 1
Nanotherapeutics Plus Immunotherapy in Oncology: Who Brings What to the Table?
Élise Timon-David, Carla Perez, Anne Rodallec
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2326-2326
Open Access | Times Cited: 2
Élise Timon-David, Carla Perez, Anne Rodallec
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2326-2326
Open Access | Times Cited: 2
